IHS Chemical Week

Archives :: Regions :: Western Europe :: Switzerland

Displaying 401 - 420 of 537 stories.
October 23, 2009
Crop protection sales were 10% lower, to $1.6 billion, while seed sales increased 3%, to $406 million....
October 22, 2009
Lonza says it has signed an investment agreement, including a right of first refusal for the commercial production of products, with innovative biotechnology company Cilian...
October 20, 2009
Lonza says it has withdrawn its previously announced non-binding proposal to acquire all of the outstanding restricted voting shares of pharmaceutical contract manufacturing and...
October 16, 2009
Lonza says it has acquired the preclinical cell and molecular biology assets of Simbiosys Biowares India (Bangalore, India), a biology outsourcing company. In a separate move, Merck...
October 14, 2009
Solvias (Basel, Switzerland) and Evonik say they have renewed a license agreement for a range of vanadium-doped precious metal powder catalysts for the hydrogenation of nitro...
September 30, 2009
The cuts form part of a restructuring of the company's operations in Europe....
September 28, 2009
Lonza says pharmaceutical contract manufacturing and development services company Patheon (Toronto), and Lonza have agreed to extend the exclusivity and due diligence period until...
September 10, 2009
Clariant’s focus for the next few years will be on restructuring as well as cash preservation and generation to support profitability and expansion by 2011 and beyond, Hariolf...
September 3, 2009
Over 2000 climate scientists, experts and decision-makers established a Global Framework for Climate Services to strengthen production, availability, delivery and application of...
August 21, 2009
Lonza says it has submitted a non-binding proposal to acquire all of the outstanding restricted voting shares of leading pharmaceutical contract manufacturing and development services...
July 22, 2009
Lonza has recorded a 33% fall in first-half net profits on a comparable basis, to SF118 million ($110 million), compared to the year-ago period. Sales were down 9%, to SF1.32 billion...
July 21, 2009
Lonza says it has combined its Exclusive Synthesis and Biopharmaceutical business sectors into a single division called Lonza Custom Manufacturing. These changes are effective from...
July 10, 2009
The EMS Group reported a 48% drop in net operating income for the first half of 2009 to SF71 million ($65.7 million) on sales 35% lower at SF541 million. EMS Group's...
July 9, 2009
BASF will supply key component materials and electrochemistry expertise to further the development of ReVolt Technology's batteries....
June 29, 2009
Lonza says it has renewed and extended its long-time collaboration with DSM Nutritional Products at their production facilities at Visp and Lalden, Switzerland, for supplying services...
Pages: « Previous  12 13 14 15 16 17 18 19 20 [21] 22 23 24 25 26 27 Next »

contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa